BothPCAB
Empower Pharmacy
Houston, TX • Est. 2009
SemaglutideTirzepatide49 states
Empower Pharmacy is a Houston-based compounder that runs a 503A pharmacy and Empower Pharma, an FDA-registered 503B outsourcing facility it describes as the nation's largest; a second Empower 503B site in East Windsor, New Jersey is also registered with FDA. Empower supplies compounded semaglutide and tirzepatide to many of the nation's largest telehealth brands and operates its 503B under cGMP requirements. FDA issued warning letters to both the 503B and the 503A in April 2025, and a September 2026 warning letter to the 503A said some of its compounded semaglutide and tirzepatide products appear to be essentially copies of FDA-approved drugs.
View Details →
Both
Belmar Pharmacy
Lakewood, CO • Est. 1985
50 states
Belmar Pharmacy (now operating as Belmar Pharma Solutions) is a national compounding organization founded in 1985 in Colorado. It lists 503A pharmacies in Golden, CO, Odessa, FL, Wichita, KS, Youngtown, AZ, and Madison, WI, and 503B outsourcing facilities (Belmar Select Outsourcing) in Golden and Lakewood, CO. It lists NABP accreditation, LegitScript certification, and a California sterile license among its credentials. Its own GLP-1 FAQ says it compounds liraglutide (as a combination injectable with L-carnitine), not semaglutide or tirzepatide.
View Details →
BothPCAB
Olympia Pharmaceuticals
Orlando, FL • Est. 2009
SemaglutideTirzepatide0 states
Olympia Pharmaceuticals (Olympia Pharmacy; legal entity OPS International, Inc.) is a dual 503A/503B compounding pharmacy based in Orlando, Florida, founded in 2009 and licensed in 49 states. It is FDA-registered as a 503B outsourcing facility and produces sterile injectable compounds including GLP-1 medications. FDA has issued Form 483s to the 503B facility in 2022, 2024, 2025, and September 2026.
View Details →
503APCAB
Innovation Compounding
Kennesaw, GA • Est. 2007
SemaglutideTirzepatide48 states
Innovation Compounding is a 503A pharmacy in Kennesaw, Georgia, founded in 2007 as a family-owned operation. Acquired by Revelation Pharma in January 2022. PCAB accreditation granted June 2024 via ACHC. Reportedly serves over 45 states; it ships only non-sterile preparations to California, so it cannot send injectable GLP-1s there.
View Details →
503A
Absolute Pharmacy
Lutz, FL
SemaglutideTirzepatide0 states
Absolute Pharmacy is a LegitScript Healthcare Merchant-certified (Sept 15, 2021) 503A compounding pharmacy in Lutz, Florida. Its site says it is licensed for prescription fulfillment nationwide, covering 46 continental states plus Alaska and Hawaii, but does not list the states. Operates proprietary eRX software that automates state-licensing checks for telehealth prescribers. Its homepage lists weight-loss compounding (semaglutide, tirzepatide) alongside sexual health, hormone replacement, fertility, hair loss, sleep, and anxiety. The California State Board of Pharmacy placed its nonresident permit on probation from November 2023 through November 2027.
View Details →
503APCAB
Shields Pharmacy
Dunedin, FL
SemaglutideTirzepatide50 states
Shields Pharmacy is a LegitScript-certified, PCAB-accredited sterile and non-sterile compounding pharmacy in Dunedin, Florida (FL pharmacy license PH32060, status Clear through 2/28/2027). Offers nationwide compounding services across all 50 states + Puerto Rico to over 5,000 healthcare providers, with an industry-leading ~48-hour turnaround. Compounds weight-management, bio-identical hormone replacement, and veterinary preparations. (Not to be confused with Shields Health Solutions, a specialty pharmacy facilitator for brand-medication insurance navigation.)
View Details →
503APCAB
MediVera Compounding Pharmacy
Troy, MI • Est. 1999
50 states
Troy, MI 503A compounding pharmacy founded in 1999, PCAB-accredited in both sterile and non-sterile compounding, a dual accreditation held by fewer than 1% of US compounders. For weight management its site lists compounded liraglutide injection and does not mention semaglutide or tirzepatide. It ships to 49 states plus DC (not California), with third-party potency, sterility, and endotoxin testing.
View Details →
BothPCAB
Wells Pharmacy Network
Ocala, FL
SemaglutideTirzepatide0 states
Wells Pharmacy Network is a compounding pharmacy network that operates a 503A pharmacy in Ocala, Florida and an FDA-registered 503B outsourcing facility in Dyersburg, Tennessee. Focuses on wellness, weight management, and hormone compounding. FDA issued Form 483s to the Dyersburg 503B in April 2025 and April 2026 and untitled letters in 2022 and 2025.
View Details →
503A
Red Rock Pharmacy
Springville, UT • Est. 2017
SemaglutideTirzepatide49 states
Red Rock Pharmacy (CD Pharmacy LLC) is a Utah-based 503A state-licensed compounding pharmacy with locations in Springville and St. George. Its Springville site serves every state except California, Nevada, and Arkansas, and the St. George site serves California and Nevada, for 49 states in all. Produces sterile injectables including compounded semaglutide and tirzepatide. FDA issued a Form 483 to the Springville facility in July 2026.
View Details →
503A
Epiq Scripts
Richardson, TX
SemaglutideTirzepatide50 states
Epiq Scripts is a Texas-based mail-order compounding pharmacy headquartered in Richardson, TX, founded in 2022 by Sultan Haroon and Maja Matthews. It positions itself as a white-label, API-driven 503A pharmacy partner for telehealth brands, offering high-volume prescription fulfillment, non-sterile custom compounding, custom-branded packaging, and nationwide UPS shipping. LegitScript-certified per a 2025 LegitScript customer-spotlight Q&A with co-founder Sultan Haroon.
View Details →
Mail-Order
Amazon Pharmacy
, • Est. 2020
SemaglutideTirzepatide0 states
Amazon Pharmacy is a national mail-order pharmacy that dispenses FDA-approved branded GLP-1 weight-loss medications (not compounded). It carries the oral Wegovy and Foundayo pills with cash-pay pricing starting around $149 per month, and injectable Wegovy, the Zepbound auto-injector, and the Zepbound KwikPen with cash-pay pricing starting at $199 per month. It also delivers GLP-1 medications to eligible Medicare patients for $50 a month. Insured patients can pay as low as $25 per month for the oral options. Medications ship to all 50 states, with same-day delivery available in thousands of cities. Amazon also runs a GLP-1 management program through Amazon One Medical.
View Details →
SemaglutideTirzepatide0 states
Costco Pharmacy is a national membership-warehouse retail pharmacy that dispenses FDA-approved brand GLP-1 medications and does not compound. Under Costco Member Value Pricing it fills Wegovy and Ozempic at Novo Nordisk's self-pay prices — $199 a month for the two starter doses for two fills, then $349, with Wegovy HD 7.2 mg at $399 and Wegovy tablets from $149. It also lists Zepbound KwikPens at $499.22 a month for 2.5 to 7.5 mg and $699.21 for 10 to 15 mg (warehouse pick-up), and Mounjaro at $1,103.95 per box of four pens.
View Details →
SemaglutideTirzepatide0 states
Walmart Pharmacy is a national retail chain of nearly 4,600 pharmacies that dispenses FDA-approved brand GLP-1 medications and does not compound. It was the first retail pick-up option for LillyDirect's self-pay Zepbound single-dose vials, and LillyDirect also lists Walmart pick-up for the KwikPen: $299 a month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg through 15 mg when the prescription is refilled within 45 days. We found no Walmart cash price of its own for Wegovy, Ozempic or Mounjaro; Novo Nordisk's self-pay offer applies at the counter. Its Better Care Services platform adds virtual care and nutrition partners.
View Details →
503B
FarmaKeio Outsourcing
Southlake, TX
SemaglutideTirzepatide0 states
FarmaKeio Outsourcing is the FDA-registered 503B arm of the FarmaKeio Pharmacy Network, a Texas-based custom compounding operation that produces sterile formulations including semaglutide and tirzepatide combinations. FarmaKeio is a lead plaintiff, alongside the Outsourcing Facilities Association, in litigation challenging the FDA's removal of tirzepatide from the drug shortage list.
View Details →
503APCAB
Curexa Pharmacy
Egg Harbor Township, NJ • Est. 2003
SemaglutideTirzepatide0 states
Curexa Pharmacy is a PCAB-accredited and LegitScript-certified 503A compounding pharmacy in Egg Harbor Township, New Jersey, founded in 2003, that compounds prescriptions nationwide including GLP-1 weight-loss medications such as semaglutide and tirzepatide. It is a frequently named back-end fulfillment pharmacy for telehealth platforms.
View Details →
503APCAB
Chemistry Rx
Folcroft, PA
SemaglutideTirzepatide0 states
Chemistry Rx is a 503A compounding and specialty pharmacy near Philadelphia (Folcroft, PA), licensed in all 50 states. It lists PCAB accreditation for USP 795 and 800, ACHC accreditation in specialty and rare disease, and NABP Healthcare Merchant Accreditation. Its site focuses on dermatology, hair loss, rare disease, and mitochondrial and metabolic disorders.
View Details →
503A
Beaker Pharmacy
McKinney, TX • Est. 2018
SemaglutideTirzepatide0 states
Beaker Pharmacy is an independent retail and sterile compounding pharmacy located at 7810 Eldorado Parkway, Suite 200, McKinney, TX 75070. Opened in 2018. Compounds GLP-1 medications (semaglutide and tirzepatide) along with hormones, dermatology preparations, pediatric formulations, and other specialty compounds. Reportedly serves 45+ states.
View Details →
503A
Striker Pharmacy
Katy, TX
SemaglutideTirzepatide1 states
Striker Pharmacy LLC (branded StrikerRx) is a 503A sterile compounding pharmacy in Katy, Texas (1330 Pin Oak Rd, 77494) serving licensed prescribers. Its redesigned site lists weight management and metabolic health among its compounding areas, and telehealth partners name it as a pharmacy for compounded GLP-1 therapy. Operates a B2B-focused model with separate intake forms for doctors and patients; offers wholesale supply for medical practices.
View Details →
503A
Promise Pharmacy
Palm Harbor, FL • Est. 2006
SemaglutideTirzepatide0 states
Promise Pharmacy is a LegitScript-certified 503A compounding pharmacy founded in 2006 and headquartered in Palm Harbor, Florida that compounds patient-specific semaglutide and tirzepatide (GLP-1) for clinics and providers. It follows USP 795/797/800 standards, performs third-party potency and sterility testing on GLP-1 batches with Certificate of Analysis documentation, and says it holds 42 state licenses. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved.
View Details →
503A
FarmaKeio Custom Compounding
Richardson, TX
SemaglutideTirzepatide0 states
FarmaKeio Custom Compounding (legal entity North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding, Richardson, TX) is the 503A patient-specific compounding pharmacy within the Texas-based FarmaKeio Pharmacy Network, offering custom sterile and non-sterile formulations including semaglutide and tirzepatide combinations for weight management. FDA issued it a warning letter in November 2022 over sterile-production deficiencies and closed the letter out in January 2026.
View Details →
503A
Skip's Pharmacy
Deerfield Beach, FL
SemaglutideTirzepatide0 states
Skip's Pharmacy is a 503A compounding pharmacy in Deerfield Beach, Florida that has served the MS, autoimmune, and low-dose-naltrexone communities for over 20 years and compounds GLP-1 weight-loss medications including semaglutide and tirzepatide for human and veterinary patients.
View Details →
503A
DCA Pharmacy
Franklin, TN
49 states
DCA Pharmacy is one of the largest 503A compounding pharmacies in Tennessee, located in Franklin, TN, and licensed to ship to 48 states. Specializes in bio-identical hormone replacement, topical pain management, scar therapy, pellet therapy, and sterile compounding. Named in a 2023 Novo Nordisk lawsuit over compounded semaglutide. Its rebuilt website no longer lists semaglutide, tirzepatide, or other GLP-1 products.
View Details →
SemaglutideTirzepatide0 states
SmartPharmaRX is a 503A licensed compounding pharmacy compounding sterile preparations in accordance with USP 797 (with USP 795 / 800 alignment) and cGMP-aligned protocols. Compounds GLP-1 therapies including tirzepatide and semaglutide, with each preparation tested for sterility, potency, endotoxin, and stability before release. It says it is currently licensed in 32 states, with more pending; the per-state list appears only on an interactive map.
View Details →
503A
SouthEnd Pharmacy
Houston, TX
SemaglutideTirzepatide41 states
SouthEnd Pharmacy is a LegitScript-certified 503A sterile compounding pharmacy in Houston, Texas, with a 55,200 sq ft facility offering next-day cold-chain delivery and licensed coverage across 40 states. Compounds semaglutide and tirzepatide with B6/pyridoxine, sources APIs only from FDA-registered manufacturers, and publishes Certificates of Analysis and potency reports on each batch.
View Details →
SemaglutideTirzepatide45 states
ReviveRX is a 503A mail-order compounding pharmacy in Houston, Texas (3831 Golf Dr., 77018) founded in 2016 with compounding operations launched in 2018. Ships to 44 states plus Puerto Rico; provider-portal model, no insurance billing. Advertises 'Weight Loss' and 'Peptide & Longevity' among its compounded-medication categories alongside hormone, sexual wellness, and dermatology preparations. Self-attests FDA-registered vendor procurement, USP-compliant sterile/non-sterile clean rooms, and a 'successful FDA inspection,' but does NOT display LegitScript or PCAB accreditation badges. FDA issued it a warning letter in September 2025 over sterile drugs prepared under insanitary conditions and a new Form 483 in March 2026, and it recalled compounded tirzepatide in 2023 and 2024. Specific GLP-1 drug names are gated behind provider-portal login.
View Details →
SemaglutideTirzepatide34 states
TruMedsRx (TMRX; legal entity Beauty Empower Rx, LLC) is a LegitScript-certified 503A mail-order sterile compounding pharmacy headquartered in Fairfax, Virginia, licensed in 34 states and serving over 85,000 patients through USP-compliant cleanroom facilities. It is one of three publicly named 503A pharmacy partners (with Rite-Away and Vios) used by telehealth provider Enhance.MD for compounded GLP-1 (semaglutide and tirzepatide), and reportedly has no disciplinary history. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved.
View Details →
503A
Stonegate Pharmacy
Austin, TX • Est. 2007
SemaglutideTirzepatide0 states
Stonegate Pharmacy is a 503A compounding pharmacy in Austin, Texas, established in 2007, with a second location in San Antonio, that compounds GLP-1 medications including semaglutide and tirzepatide as once-weekly subcutaneous injectables and sublingual rapid-dissolving tablets. It received an FDA State Referral Letter in 2020 after a 2019 inspection noted sterile-practice deviations.
View Details →
SemaglutideTirzepatide0 states
BPI Labs is an FDA-registered 503B outsourcing facility and injectable drug manufacturer in Largo, Florida. It historically produced compounded semaglutide and tirzepatide injectables at scale for telehealth brands (notably Hims & Hers), and Belle Health still lists it as its tirzepatide manufacturer, although BPI's own products page lists no GLP-1 products. FDA issued it a Form 483 after an April 2026 inspection.
View Details →
503A
Enovex Compounding Pharmacy
Glendale, CA
SemaglutideTirzepatide9 states
Enovex Compounding Pharmacy is a 503A sterile and non-sterile compounding pharmacy in Glendale, California that compounds GLP-1 medications for telehealth weight-loss partners. It says it is licensed to deliver to patients in California, Arizona, Colorado, Connecticut, Illinois, North Carolina, Pennsylvania, Washington, and Wisconsin.
View Details →
503APCAB
APS Pharmacy
Palm Harbor, FL
Semaglutide0 states
APS Pharmacy (Drug Depot, LLC) is a 503A compounding pharmacy in Palm Harbor, Florida listed as producing compounded semaglutide. FDA now addresses it as "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy," at Belmar Pharma Solutions' Lakewood, Colorado office, and its former website no longer resolves. FDA issued it a warning letter in March 2023, which was closed out in October 2023.
View Details →
503A
Optimal Balance Pharmacy
Houston, TX
SemaglutideTirzepatide32 states
Optimal Balance Pharmacy (operating as OBPRX) is a 503A sterile compounding pharmacy at 2204 Cypress Creek Pkwy Ste F&G, Houston, TX 77090. NPI 1306535307. Owner Christopher Quintana. Inspected by the Texas State Board of Pharmacy and via the NABP Verified Pharmacy Program (VPP); USP <795>/<797>/<800> compliant; PCCA member for API sourcing. The pharmacy lists GLP-1 compounding among its sterile-lab specialties but does not publicly enumerate specific products on its public website as of May 2026. Its licensure page lists 31 states plus DC as licensed, with 18 more states marked license pending.
View Details →
503A
Rush Pharmacy
Oviedo, FL
SemaglutideTirzepatide0 states
Rush Pharmacy is a compounding pharmacy headquartered at 1977 Alafaya Trail #1121, Oviedo, FL 32765, with a second location in Plano, Texas. The website markets customized compounded medications and supplements with 48-hour shipping and all-inclusive pricing across weight management, hormone, hair growth, and sexual wellness categories. The marketing copy on the homepage states the pharmacy is 'pending licensure in all 50 states' (not yet licensed in all 50 states) even though the embedded JSON-LD MedicalOrganization markup claims '50-state' licensure. Named pharmacy partner of Bodyshop Wellness.
View Details →
503A
Rite-Away Pharmacy
San Antonio, TX
SemaglutideTirzepatide28 states
Rite-Away Pharmacy & Medical Supply is a 503A sterile and non-sterile compounding pharmacy serving San Antonio and Austin, Texas. It is one of three publicly named 503A pharmacy partners (with Vios and TruMedsRx) used by telehealth provider Enhance.MD for compounded GLP-1, and reportedly has no disciplinary history. Services include retail prescriptions, sterile and non-sterile compounding, infusions, medical supplies, long-term care, and free delivery. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved.
View Details →
503B
Wells Pharma of Houston
Houston, TX
SemaglutideTirzepatide0 states
Wells Pharma of Houston is an FDA-registered 503B outsourcing facility in Houston, Texas that compounded sterile injectables including semaglutide and tirzepatide for clinics and providers during the GLP-1 shortage era. It received an FDA Form 483 in March 2025, an FDA Warning Letter in November 2025 for sterility-assurance and 503B-compliance deficiencies, an amended Form 483 in April 2026, and April 2026 recalls of injectable products for cGMP deviations. It is a separate legal entity from the Wells Pharmacy Network of Ocala, Florida.
View Details →
503A
The Pharmacy Hub
Miami, FL
SemaglutideTirzepatide0 states
The Pharmacy Hub is a 503A compounding pharmacy at 15600 NW 15th Ave Suite C, Miami, FL 33169, named by CLYR Health as its dispensing partner for compounded semaglutide and tirzepatide. It describes itself as a large-scale fulfillment pharmacy shipping to all 50 states and Puerto Rico from a national campus in Davie, Florida.
View Details →
Both
Carie Boyd Pharmaceuticals
Irving, TX
Semaglutide0 states
Carie Boyd Pharmaceuticals is a Texas-based compounding pharmacy operated by Right Value Drug Stores, LLC. The company runs an FDA-registered 503B outsourcing facility at 8400 Esters Blvd, Suite 190, Irving, TX 75063 (registered with FDA as an outsourcing facility on July 3, 2019), which FDA's current outsourcing-facility list registers as Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop, plus a 503A patient-specific compounding pharmacy doing business as Carie Boyd's Prescription Shop in Denton, TX (also referenced at 122 Grapevine Hwy, Hurst, TX per NPPES NPI 1205253085, Texas pharmacy license 165). The 503A pharmacy roots trace to a community pharmacy founded in 1965 in the Dallas-Fort Worth area. For GLP-1 weight management, Carie Boyd markets a sublingual semaglutide suspension compounded exclusively with commercially available Rybelsus tablets in a SubMagna sublingual base (starting dose 1 mg/day, titrated to ~1.5 mg/day); no public marketing was found for compounded tirzepatide. The company received an FDA Warning Letter on December 17, 2024 (reference 694687) citing 503B compliance and labeling deficiencies, and a prior Warning Letter on September 20, 2021 (reference 610751) following a 2019 inspection. FDA issued a Form 483 after a September 2026 inspection of the Irving facility, and in October 2026 the company began a Class II recall of compounded testosterone cypionate for lack of sterility assurance. These actions reduce confidence in this pharmacy for telehealth-provider sourcing relative to peers without active FDA enforcement on file.
View Details →
503B
Tailstorm Health (Medivant Health)
Chandler, AZ
SemaglutideTirzepatide0 states
Tailstorm Health Inc., doing business as Medivant Health, is an FDA-registered 503B outsourcing facility in the Phoenix/Chandler, Arizona area that says it holds 48 state licenses. It previously compounded sterile semaglutide and tirzepatide injections; its current product lines (testosterone, NAD+, ophthalmics, and hospital injectables) do not include GLP-1s. It received an FDA warning letter in April 2025 for cGMP and sterility violations and missing labeling on its GLP-1 products, which FDA closed out in March 2026, and a new FDA Form 483 in August 2026.
View Details →
503A
iPharma Pharmacy
Houston, TX
SemaglutideTirzepatide5 states
iPharma Pharmacy is a licensed 503A compounding pharmacy in Houston, TX (5400 Katy Fwy) with a sterile-compounding lab and certified clean rooms. It compounds across many areas, including HRT, dermatology, dental, veterinary, and weight loss. Through its online telehealth storefront it now sells compounded tirzepatide/glycine injectables starting at $249 and semaglutide/glycine injectables starting at $165, and it still markets its in-house 'iSlimWell' formula. It says it is licensed to serve patients in 21 states, with sterile compounding licenses in TX, AZ, and NY.
View Details →
503A
Emerald Compounding Pharmacy
Tampa, FL
SemaglutideTirzepatide0 states
Emerald Compounding Pharmacy is a 503A sterile and non-sterile compounding pharmacy in Tampa, Florida, licensed by the Florida Department of Health for sterile (PH35337) and non-sterile (PH35074) compounding. It states LegitScript certification on its site. Society of You, EverSlim, and WellMedRx name it among their dispensing pharmacies for compounded GLP-1 medications.
View Details →
503A
Foothills Professional Pharmacy
Tempe, AZ
SemaglutideTirzepatide0 states
Foothills Professional Pharmacy is a 503A compounding pharmacy in Tempe, Arizona, licensed across all 50 states, offering white-label telehealth fulfillment. Its own site describes non-sterile compounding only, following USP <795> and <800>, so it does not state that it compounds injectable GLP-1s. The FDA issued it a Warning Letter in 2020 over compounding without patient-specific prescriptions, and the California State Board of Pharmacy publicly reproved its nonresident permit in 2024.
View Details →
503A
Central Drugs Compounding Pharmacy
La Habra, CA • Est. 1999
SemaglutideTirzepatide0 states
Central Drugs Compounding Pharmacy is a 503A compounding pharmacy chain based in La Habra, California, founded in 1999. Its site lists bioidentical hormone replacement, thyroid, low-dose naltrexone, dermatology, sexual health, alopecia, veterinary, and glutathione compounding; it does not mention GLP-1 products, although directory listings have named it as producing compounded semaglutide and tirzepatide.
View Details →
503A
Vios Compounding Pharmacy
Livonia, MI
SemaglutideTirzepatide0 states
Vios Compounding Pharmacy (legal entity SNF Holdings, LLC dba Vios Compounding) is a 503A compounding pharmacy in Livonia, Michigan that compounds semaglutide and tirzepatide (GLP-1), including injectable vials (1 mg or 5 mg strength in 1 mL or 2.5 mL) and GLP-1 oral strips/transmucosal films, prepared per individual prescription. The FDA issued a state referral letter to the pharmacy in April 2024. Note: routine 503A compounding of GLP-1s that copy commercially available products is restricted now that the FDA shortages are resolved. Enhance MD names it in its pharmacy disclosures as a GLP-1 compounding and fulfillment partner.
View Details →
503A
Midtown Express Pharmacy
Nashville, TN • Est. 2012
33 states
Midtown Express Pharmacy is a non-sterile compounding pharmacy in Nashville, Tennessee, founded in 2012 by Brian Williams, PharmD. Specializes in retail, long-term care, and non-sterile compounded preparations (including LDN, hormone, and oral weight-management formulations). Does NOT compound sterile injectables, so injectable compounded semaglutide and tirzepatide are not produced here — only non-injectable oral or sublingual forms if offered. Licensed in 33 states (counting DC). A 2024 consent judgment in a Novo Nordisk lawsuit permanently bars it from marketing or selling compounded semaglutide; legal entity is Dunklau Pharmacy Holdings, LLC.
View Details →
503A
Boothwyn Pharmacy
Kennett Square, PA
SemaglutideTirzepatide0 states
Boothwyn Pharmacy is a 503A compounding pharmacy in Kennett Square, Pennsylvania that compounded sterile semaglutide and tirzepatide injections. It has an extensive regulatory history including 2018 and 2025 FDA warning letters (the 2025 letter concerned veterinary drugs), a July 2025 subpotency recall of compounded semaglutide, a 2025 Pennsylvania $1 million fine and probation over unlicensed compounding of roughly 30,000 weight-loss-drug doses, a 2025 California cease-and-desist order on sterile compounding (lifted in July 2025), and a January 2026 FDA warning letter. Boothwyn ceased production of sterile GLP-1 products in 2025 and on August 20, 2025 notified FDA of its intent to resume; its current GLP-1 production status is not publicly stated.
View Details →
503A
Aequita Pharmacy
Kirkland, WA
SemaglutideTirzepatide0 states
Aequita Pharmacy is a 503A compounding pharmacy in Kirkland, Washington that compounded semaglutide and tirzepatide injectables, including for telehealth brand Mochi Health. Washington's Department of Health issued a Limited Stop Service order against the pharmacy, citing untrained and unqualified staff performing sterile compounding and failure to follow sterile procedures. Mochi Health moved its patients to other pharmacies and says it will not resume work with Aequita until the department confirms full compliance.
View Details →